Mapping the DNA inside our energy factories — one cell at a time
Mitochondria have their own DNA, and errors in it accumulate as we age.
Scientists report in Science a method for mapping the mitochondrial genome — the small, circular piece of DNA housed inside our cellular power plants — with unprecedented precision at the single-cell level. The approach, which the researchers describe as ‘beads on a string’, allows scientists to see not only which mutations are present in mitochondrial DNA, but also how they are distributed across individual cells and how that distribution relates to cell health.
That is a significant technical advance. Mitochondria are the energy factories of the cell, producing ATP — the fuel that drives virtually all cellular processes. Each cell contains hundreds to thousands of mitochondria, and each mitochondrion carries multiple copies of its own genome. With ageing, damaged versions of that genome accumulate — a process linked to everything from muscle weakness to neurodegenerative disease. But precisely measuring that accumulation in individual cells has, until now, been technically extremely difficult.
Why measuring cell by cell changes what we can learn
Previous measurement methods averaged results across entire tissues or cell populations. That is roughly equivalent to assessing the health of a city by blending a single blood test from everyone together. Individual cells can vary enormously in their mitochondrial mutation profile — some cells are heavily affected while neighbouring cells remain healthy. That heterogeneity matters biologically: it is likely the most severely affected cells that contribute most to tissue damage and age-related disease.
The new method makes that cell-by-cell variation visible. It opens new avenues for fundamental research: scientists can now study how mitochondrial mutations spread across time and tissues, which cell types are most vulnerable, and whether interventions — from lifestyle changes to drugs — genuinely reduce mutation rates or merely improve averages while damaged cells persist undetected.
Clinical applications remain distant, but the technique itself is immediately useful as a research tool. In a field where reliable biomarkers for mitochondrial ageing are still largely absent, a method that can characterise individual cells is a meaningful addition — even if, for now, it raises more questions than it answers.